Phase 2 Asthma Trial, Recruiting NCT07324707 Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. Condition: Asthma
Back to Asthma

Phase 2 Asthma Trial, Recruiting

NCT07324707
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old (any gender)
  • You have been diagnosed with bronchial asthma — this includes a new diagnosis, or asthma first diagnosed in childhood or teenage years that has become more noticeable or worse in adulthood
  • Breathing tests before joining the trial show your lung function is within a specific moderate range (60%–85% of what is expected for someone your age and size)
  • Within the past year, at least one test has shown that your airways have variable airflow limitation — for example, your breathing improved significantly after using a reliever inhaler, your airways reacted to a trigger substance during a test, or your peak flow readings varied by more than 10% on average over 7 days
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You are unable to use a nebuliser (a device that turns liquid medicine into a mist to breathe in), cannot tolerate this type of treatment, or did not pass training on how to use it correctly
  • You have another lung condition such as COPD, bronchiectasis, pulmonary fibrosis, or tuberculosis (confirm with trial site if your asthma is still considered the main condition)
  • You have another significant condition that affects how your lungs work, such as problems with the chest wall, diaphragm, or muscles involved in breathing
  • You have a history of serious heart problems such as heart failure, coronary artery disease, heart attack, irregular heartbeat, or consistently high blood pressure that is not controlled
  • You have an overactive thyroid (hyperthyroidism) that the doctor feels makes it unsafe for you to join
  • You have a serious history of blood, liver, psychiatric, kidney, or other diseases that the doctor feels would put you at risk or affect the results
  • You have had a cancer diagnosis in the past 5 years (some exceptions may apply — confirm with trial site)
  • You have had, or are expected to need, an organ or bone marrow transplant within the next year
  • Your blood test during screening shows low potassium levels
  • You have Type 1 diabetes, or Type 2 diabetes that is not well controlled (with a fasting blood sugar above a certain level during screening)
  • You currently have a fungal infection in your mouth, throat, or food pipe (candidiasis)
  • Your liver or kidney function tests during screening are above a certain level of abnormality
  • You have active hepatitis B or hepatitis C infection (at certain levels in the blood), HIV, or a history of AIDS
  • You are known to be allergic to inhaled corticosteroids (steroid inhalers) or salbutamol (a common reliever inhaler)
  • You have had a respiratory infection, sinus infection, or middle ear infection within 4 weeks before or during the run-in period that the doctor feels could affect your asthma
  • Your asthma has gotten significantly worse and needed steroid tablets or injections within 4 weeks before or during the run-in period, or you are currently taking oral (swallowed) steroids for asthma or another condition
  • You have taken, or need to take during the trial, certain strong medications that affect how the body breaks down drugs (called strong CYP3A4 inhibitors — examples include ritonavir, ketoconazole, and clarithromycin; confirm with trial site)
  • You stopped smoking less than 1 year ago, or you have a smoking history of more than 10 pack-years (this includes cigarettes, cigars, pipes, and e-cigarettes)
  • You have had problems with drug misuse or alcohol dependence in the past 2 years (heavy alcohol use is defined as more than 2 standard drinks per day on average)
  • You are pregnant, breastfeeding, or planning to become pregnant during the trial
  • You have taken part in another clinical trial within the past month
  • The doctor running the trial has another reason they feel makes it unsuitable for you to join

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Wei Zuo, The First Affiliated Hospital of Nanchang University

Phone: 86-15618775927

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Anhui Palo Alto Pharmaceuticals, Inc.
Registry
ClinicalTrials.gov
Start date
15 October 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Evaluation the change in morning pre-dose forced expiratory volume in one second (FEV1) from baseline to week 4 of treatment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov